T1	Participants 0 60	Treatment of renal failure associated with multiple myeloma.
T2	Participants 259 289	patients with multiple myeloma
T3	Participants 348 417	Twenty-one patients with active myeloma and progressive renal failure
T4	Participants 706 777	Of 5 patients who were oliguric and undergoing dialysis at presentation
T5	Participants 832 855	Of 16 polyuric patients
